The Global Medical Forum
Event RegistrationU.S. SummitsEurope SummitsMiddle East SummitsFar East SummitsGlobal Medical Forum IGlobal Medical Forum IIGlobal Medical Forum IIIGlobal Medical Forum IVGlobal Medical Forum V
 
 

Speaker & Panelist Biographies

Ms. Jill A. Berger
Vice President, Health & Welfare Plan Management and Design
Marriott International, Inc.
Jill Berger is the Vice-President, Health & Welfare Plan Management and Design for Marriott International, a leading hospitality company with 130,000 employees nationwide. Jill is responsible for the strategy, design and management of Marriott's benefit plans - with an emphasis in health plan quality improvement. She serves on the NCQA Purchaser Advisory Council, is an active member of the Leapfrog Group for Patient Safety, and serves on the Executive Client Advisory Groups for Aetna, Kaiser and eValue8. Jill is also President of the Mid-Atlantic Business Group on Health. Prior to working for Marriott, she was with Kaiser Permanente, working in conjunction with General Motors as a Health Plan Manager. She managed the health plans in the eastern part of the U.S., representing 400,000 GM employees and retirees. Prior to working with General Motors, Jill managed the medical plans for Sears, Roebuck and Company. Jill obtained her Bachelor of Arts degree from Mount St. Mary's College and her MSA from Johns Hopkins University.

Prof. Jörg F. Debatin, MD, MBA
Professor & Medical Director Chief Executive Officer
University Medical Center Hamburg-Eppendorf
Professor Debatin was appointed Medical Director and Chief Executive Officer of the University Medical Center Hamburg-Eppendorf in October 2003. In this position he is responsible for one of Germany's largest Medical Centers encompassing 6,500 employees and providing healthcare to more than 6,000 in-house patients as well as more than 100,000 ambulatory care patients. In his position as Chief Executive Officer Professor Debatin oversees an annual budget of Euro 430 million with Euro 160 million spent on medical supplies. Furthermore, Professor Debatin is responsible or Germany's largest Medical Center construction site. Thus, the University Medical Center Hamburg-Eppendorf will spend in excess of Euro 300 billion over the next four years providing new hospital infrastructure. As with most other University Hospitals, the University Medical Center Hamburg-Eppendorf is state owned. Since October 2001, the Medical Center acts however, as an independent entity, required to survive in an evermore, competitive healthcare market. At the same time, the University Medical Center Hamburg-Eppendorf harbours a School of Medicine encompassing over 3,200 Medical Students and is one of Germany's most renowned Centers for medical research. Professor Debatin gained considerable notoriety in Germany with his decision to leave the position of Chairman and Professor of Diagnostic Radiology at the University Hospital of Essen to take over the directorship of the University Medical Center Hamburg-Eppendorf. Having been the youngest academic radiologist who has ever been appointed Chairman and Professor of a University Department in Germany, Jörg Debatin was very successful in building an academic and clinical career. Together with his team, he became quickly known for a multitude of innovative ideas. His Residency in Diagnostic Radiology at Duke University Medical Center (1987 - 1992) and a subsequent fellowship at Stanford University in Abdominal Imaging (1992 - 1993) had laid the ground work for his success. Subsequently, he served as Assistant and Associate Professor of Radiology as well as Chief of Magnetic Resonance Imaging at the University Hospital in Zürich. Professor Debatin rounded his training with an "Executive MBA" programme at the University of St. Gallen, Switzerland. His decision to leave academic and clinical medicine in favour of a management position as head of a large University Medical Center has been interpreted as a reflection of the increasing independence of large University Medical Centers from their public owners. Over the past year Professor Debatin has been associated with much change at the University Medical Center in Hamburg. The institution is restructuring itself both, regarding its organisational framework as well as its strategic goals. Under his stewardship Hamburg-Eppendorf is aiming to reach a pole position in the rapidly changing German health-care market.

Mr. Andrew Dillon
Chief Executive
The National Institute for Clinical Excellence (NICE)
Mr. Dillion graduated from the University of Manchester in 1975 and has held a number of senior management positions in the UK National Health Service, including General Manager of the Royal Free Hospital and Chief Executive of St George's Healthcare NHS Trust, both academic centres in London. He has been a member of the Council of the NHS Trust Federation and has contributed to national policy on the allocation of research and development funding in the NHS. He has been a member of the UK Department of Health's International Panel and its Health Industries Task Force. An experienced speaker, he has contributed to a number of international policy forums, including an OECD review of approaches to the adoption of new and emerging health related technologies and the EC funded European Collaboration for Assessment of Health Interventions project. He is currently a non-executive director of HTAi an international collaboration of agencies, individuals and corporations involved in the development and application of health technology assessment. He helped establish NICE as its founding Chief Executive in1999. NICE sets health care standards for the National Health Service in England and Wales.

Mr. Martin L. "Chip" Doordan
President
Anne Arundel Health System, Inc.
Martin L. "Chip" Doordan is President of Anne Arundel Health System, Inc., a not-for-profit corporation based in Annapolis, Maryland, which offers a broad range of health care services. The Health System encompasses the Anne Arundel Medical Center located at the Carl A. Brunetto Medical Park. The System also includes Pathways, a substance abuse treatment center, an extensive outpatient network of services, and community health education. Mr. Doordan served as an Officer in the Medical Service Corp. of the United States Army from 1968-1971. During that time period, he was stationed at Fort Meyer, Virginia and the Republic of Vietnam. Mr. Doordan joined Anne Arundel Medical Center in 1972 while pursuing a graduate degree in health care administration at George Washington University and remained after its completion. He served in positions of increasing responsibility, and in 1988 became President of Anne Arundel Medical Center. In 1994, the Board of Trustees named Mr. Doordan President of the Health System. Mr. Doordan received his undergraduate degree from the University of Delaware, and in addition to his Masters of Arts degree in Health Care Administration from George Washington University, he has a Masters of Science degree from the University of Maryland. He is a Fellow in the American College of Healthcare Executives. Mr. Doordan has been the recipient of the Anne Arundel Trade Council's President Award, the Martin Luther King, Jr. Drum Major Award and the Anne Arundel Trade Council's Business Leader of the Year Award. Mr. Doordan is a 2001 graduate of Leadership Maryland and currently serves on the Boards of United Way of Anne Arundel County, Hospice of the Chesapeake, and First Night Annapolis. He also serves as a guest lecturer for the Military Health System Capstone Symposium, which brings a civilian perspective to the military aspects of our armed forces.

Dr. Jenifer Ehreth, PhD
Director of Economics and Reimbursement
Medtronic Europe, Sàrl
In her current position, Dr. Ehreth is responsible for economic analyses in support of health care treatments, and in this context, works with government payers. She meets with policymakers and thought leaders across Europe on issues of system reform and patient access. Prior to this position, she was Vice President for Economics and Pricing Worldwide for Aventis Pasteur in Lyon, France. Here she completed numerous evaluations of the economic impact of vaccination and published numerous articles on the topic. From 1995 to 1999, she was responsible for the Corporate Health Economic Departments of SmithKline Beecham and then Bristol Myers Squibb. Prior to joining industry, she spent 15 years as a professor teaching and conducting outcomes and economic research at the University of Washington and has over 30 peer-reviewed articles in this area. She received a Robert Wood Johnson Faculty Fellowship in Health Care Financing and spent a year at the Prospective Payment Commission in the US Government. Before receiving her PhD, she was a Coronary Care nurse working in special care units and in open-heart surgery in hospitals in the US and in the Philippines. Jenifer has one personal aspiration and that is to be a bridge between payers and healers to improve access to appropriate patient care. She has been active in the Academy of Management, the International Health Economics Association, the Health Economics Study Group, and ISPOR.

Dr. Wendy Everett, ScD
President
New England Healthcare Institute
Dr. Everett was appointed as the first President of the New England Healthcare Institute (NEHI) in July 2002. NEHI was established to identify realistic strategies for improving health care quality while reducing health care costs. Dr. Everett leads a team that conducts independent research leading to evidence-based public and private health policy recommendations. With over thirty years of experience in the health care field, Dr. Everett brings a unique perspective to NEHI. She has held executive positions at the University of California, San Francisco Medical Center (UCSF) and at Brigham and Women's Hospital in Boston. In the 1980s, she directed a national demonstration program for The Robert Wood Johnson Foundation and subsequently was the Program Director for the national program in health promotion and disease prevention for the Kaiser Family Foundation. Dr. Everett was also the co-founder of a medical software company sponsored jointly by the Harvard Community Health Plan and Electronic Data Systems. Dr. Everett has served as a consultant to many state and national philanthropic foundations and was the coordinator of a multi-foundation consortium in AIDS prevention and evaluation at UCSF. In the mid 1990's, she became a Director of the Institute for the Future, leading the Health and Health Care research team for 6 years and overseeing the creation of ten-year, national forecasts in health/health care. She is a Trustee of many health care and philanthropic boards and currently chairs the boards of the Sierra Health Foundation and the Health Technology Center. Dr. Everett holds a B.S. degree in liberal arts and master's and doctoral degrees in health policy and management from Harvard University.

Dr. Paul Ginsburg
President
The Center for Studying Health System Change (HSC)
Founded in 1995, HSC conducts research to inform policymakers about changes in the organization of financing and the delivery of care and the effects of those changes on people. Data are gathered through the Community Tracking Study, which surveys households and physicians and conducts site visits to interview health system leaders in 12 communities that are representative of the nation. HSC is widely known for the objectivity and technical quality of its research and its success in communicating its findings to policymakers and the media as well as to the research community. Affiliated with Mathematica Policy Research, Inc., HSC receives core funding from The Robert Wood Johnson Foundation. Dr. Ginsburg served as the founding Executive Director of the Physician Payment Review Commission (now the Medicare Payment Advisory Commission). Widely regarded as highly influential, the Commission developed the Medicare physician payment reform proposal that was enacted by the Congress in 1989. Dr. Ginsburg was a Senior Economist at RAND and served as Deputy Assistant Director at the Congressional Budget Office. Before that, he served on the faculties of Duke and Michigan State Universities. He earned his doctorate in economics from Harvard University. Dr. Ginsburg is a noted speaker and consultant on the changes taking place in the health care system and the future outlook. In addition to presentations on the overall direction of change, recent topics have included cost trends and drivers, consumer driven health care, and competition in health care. Modern Healthcare twice named him one of the 100 most powerful persons in health care. He is a founding member of the National Academy of Social Insurance, a Public Trustee of the American Academy of Ophthalmology, and served two elected terms on the Board of AcademyHealth.

Mr. Thomas Grissom
Vice President, Government Affairs
Boston Scientific Corporation
Thomas Grissom is the Vice President of Government Affairs for Boston Scientific Corporation, a worldwide developer, manufacturer, and marketer of medical devices whose products are used in a broad range of interventional medical specialties. Tom manages the company's Washington, D.C. office and is responsible for a wide range of global governmental policy issues impacting Boston Scientific and the medical device industry. He works with the Congress, the Administration, key government agencies, and trade associations representing medical technology interests. From 2001-2003, Tom served as Director, Center for Medicare Management (CMM) at the Centers for Medicare & Medicaid Services (CMS). As Director of CMM, Tom had responsibility for developing reimbursement policies and regulations for the fee-for-service Medicare program in the Department of Health and Human Services. He also managed the program's 50 contractors that process 1 billion Medicare claims a year and make provider payments of more than $240 billion. Prior to joining CMS, Tom was the sole proprietor of a Washington, D.C. health care consulting firm that advised clients on a variety of policy issues affecting public health programs, hospital and nursing home reimbursement, and the development and adoption of new medical technologies. His 15 years of healthcare experience prior to moving to Washington included operational and policy experience with Louisville-based Humana, Inc., and Vencor, now Kindred Healthcare Corporation. His last position at Kindred was as Vice-president of Government Affairs. Tom is a graduate of Ohio Wesleyan University and holds advance degrees from Columbia University and Stanford University.

Ms. Anne-Kathrin Haas
Senior Officer Health Policy
AOK Bundesverband (Federal Association of Regional Health Insurance Funds in Germany)
Ms. Haas was appointed Senior Officer Health Policy as of July 2000. In this position, she is responsible for health policy analysis. Developing and introducing the company´s positions into governmental activities and legislation are another major part of her responsibility. Furthermore, she assists the President of the Board and the President of the Administrative Board in all public and corporate policy matters. Ms. Haas is AOK-Bundesverband´s expert and contact person for international delegations seeking input and solutions from the German Health Care System. Prior to her current assignment, Ms. Haas was Senior Project Member for integrated service models. From 1996 until 1998 Ms. Haas served as Manager of the Office of the Executive and Administrative Board at the Regional Association of Ambulant Physicians in Freiburg, Germany. Her responsibilities included regional contract affairs, relations with health care insurance organizations, and issue management. She is increasingly recognized as expert on a wide range of health policy issues and has published in that field. She is an appointed member of the regularly held Four Country Conference and the Global Medical Forum. Ms. Haas is an alumna of the European Health Leadership Program, held at INSEAD, Fontainebleau, France. She began her career in the Public Health Care System, after graduation from the University of Freiburg in 1996. She earned an economics degree with a special focus on health care management. A German citizen, Ms. Haas was awarded with a scholarship to study in Canada during the academic year 1993/1994. From 1986 until 1989 Ms. Haas worked in her learned profession as Commercial Banker and also as Manager of Export Sales in the Paper Industry.

Mr. Stephen A. Hull
Vice President, Global Strategy & Analysis Department
Advanced Medical Technology Association (AdvaMed)
Mr. Hulls's primary areas of responsibility concern Europe and non-Asia regions of the world. He also works on reimbursement issues in key overseas markets. Prior to coming to AdvaMed, Mr. Hull was a Principal at Covance Health Economics and Outcomes Strategies, Inc., where he designed reimbursement and market strategies for a broad range of technologies. He also has experience as a government affairs analyst and as an editor of FDA-related publications at the Thompson Publishing Group in Washington, D.C. Mr. Hull earned his B.A. (1987) in French/International Relations from Colgate University and his Master's Degree (1994) in Health Policy from the John Hopkins School of Hygiene and Public Health.

Mr. Robert Laszewski
President, Health Policy and Strategy Associates, Inc. (HPSA)
Chairman North America, Global Medical Forum Foundation
HPSA is a policy and market place consulting firm specializing in assisting its clients through the significant health policy and market change afoot. Before forming HPSA in 1992, Mr. Laszewski was Executive Vice President and Chief Operating Officer, Group Markets, for the Liberty Mutual Insurance Group. He has twenty years of health insurance industry management experience-nine of those years as a chief operating officer. The majority of Mr. Laszewski's time is spent being directly involved in the marketplace as it comes to grips with the health care cost and quality challenge. His clients include health insurance companies, casualty insurance companies, HMOs, Blue Cross organizations, hospitals, pharmaceutical companies, and physician groups. Recently, HPSA has been involved in the development of organized delivery systems, joint ventures between insurance companies and providers, joint ventures between HMOs and insurance companies, the acquisition and divestiture of blocks of health insurance business, the creation of strategies for workers' compensation carriers to manage their costs in the changing health care delivery market, and the strategic planning of numerous clients as they come to grips with their response to policy and market driven change. Mr. Laszewski is very active in the purchase and divestiture of health care and insurance businesses having been involved in a number of such transactions in recent years. Mr. Laszewski has participated extensively in the nation's health care debate, especially on health insurance reform and the impact it will have on existing health insurance programs, the insurance industry, and the evolving role between payers and providers. Bob Laszewski has written and spoken widely on the subject of health care reform and market change. His media appearances include health care features on ABC, NBC, CNN, PBS, and NPR, as well as on The McLaughlin Group and John McLaughlin's "One on One." Additionally, numerous articles about his ideas have appeared in the national and trade press and he has been regularly quoted in many newspapers including The Wall Street Journal and the Washington Post. Bob Laszewski is North American Chairman of the Zurich-based Global Medical Forum Foundation, an international network of leaders in health care policy, business, and science from over 30 nations. He also chairs the Forum's activity in China. His opinions are regularly sought by groups such as the Health Insurance Association of America, The American Academy of Orthopedic Surgeons, the American College of Physicians, the American Society of Internal Medicine, the Council for Health Information Management, and the International Foundation of Employee Benefit Plans (sponsors of the CEBS designation), as well as other trade associations, state policy makers and regulators, hospital administrators, and religious groups. He has offered his perspective on health care reform in testimony before several committees of both the House and Senate of the U.S. Congress.

Mr. Lawrence "Larry" Leisure
Senior Vice President, Sales and Account Management
Kaiser Foundations Health Plan, Inc., Kaiser Foundation Hospitals
Lawrence "Larry" Leisure is Senior Vice President, Sales and Account Management, of Kaiser Foundation Health Plan, Inc., and Kaiser Foundation Hospitals. Working with sales and marketing leaders throughout the Kaiser Permanente program, Leisure is accountable for the leadership and development of world-class sales, account management and distribution capabilities. Leisure has direct accountability for the leadership and performance of National Accounts Sales and Account Management; Major Benefit Consultant Relationships; Personal Advantage Shared Services - Individual Products (PASS); Sales Effectiveness; and Sales, and Marketing Systems Planning. In addition, he shares joint accountability with the regional vice presidents responsible for achieving membership and revenue objectives. Leisure is a member of KP's national Health Plan Operations Leadership Team (HPO-LT) and the Marketing Sales and Business Development (MSBD) leadership group. Prior to joining KP, he was Global Managing Partner, Health Services Industry, at Accenture (formerly Andersen Consulting). From 1991-1996, he was the Health & Welfare Practice Leader at Price Waterhouse. Previously, he was Group Benefits Practice Leader at Towers Perrin. Leisure is a Senior Fellow at the Institute for the Future and a frequent speaker at health and benefit forums, including the Global Medical Forum and World Health Congress. A nationally recognized health benefit consultant and change agent, Leisure has worked with many of the nation's largest employers, insurers, health plans and pharmacy benefits management firms. Leisure received his master's of business administration degree from the University of California, Los Angeles. He received his bachelor's degree from Stanford University.

Prof. Raphael H. Levey, MD
Founder and Chairman
Global Medical Forum Foundation
Dr. Levey completed his clinical training in general and thoracic surgery at the Massachusetts General Hospital and spent four years in basic research at the National Institutes of Health (NIH) in Bethesda and at the National Institute for Medical Research in London. Dr. Levey joined the Faculty of the Harvard Medical School (HMS) in the Department of Surgery at the Children's Hospital and in the Division of Medical Sciences (Immunology). He received tenure at HMS in 1975 and founded the Organ Transplantation Program at Children's Hospital, serving as Chief of Unit for over ten years and performed the first successful bone marrow, kidney and liver transplants at the hospital. He was a Moseley Fellow in Medicine at HMS, a Markle Scholar in Academic Medicine and a Faculty Research Associate of the American Cancer Society. He has held visiting Professorships at many European and North American Universities and was elected a Member of the Collège de France. He is the author of 80 scientific papers in leading refereed journals and has received grants from the American Cancer society and NIH. In the early 1970s, he developed in the laboratory and then transferred to clinical use a new class of immunosuppressive agents and, in so doing, worked closely with pharmaceutical companies and the Food and Drug Administration. In the late 1970s, Dr. Levey founded Health Care International (HCI). The company developed a private, for-profit, highest quality, university hospital in English speaking Europe, closer to an under-served market from Southern Europe, the Middle East and North Africa; the hospital provided the most advanced care for complicated illnesses at reasonable costs. Dr. Levey served as Chairman of the Company, creating what was the largest start-up company in the history of the City of London. He is the Founder of the Global Medical Forum Foundation (GMF) of which he is currently global chairman. GMF is a network of leaders and innovators in medicine, which meets every year in Zurich, Washington, Berlin, Abu Dhabi and Beijing. The mission of GMF is to make a difference in the healthcare debate by bringing the many different constituencies of healthcare into dialogue.

Dr. Catharina C. Maulbecker
Chairman Europe
Global Medical Forum Foundation
Dr. Maulbecker received her Ph.D. in Biochemistry from the University of California at Berkeley in 1989, and thereafter worked for eight years in applied medical research. She then joined McKinsey & Company and was a core member of the global healthcare and pharmaceutical practice. In this function she lectured on disease management, managed care and the emergence of biotechnology startups in Europe. She organized workshops with European providers, physicians and hospital managers on topics such as managed care, the design of hospital processes and the provision of incentives within physician networks. Dr. Maulbecker has published work on trends in European managed care and physician networks in Swiss and German medical journals, and also wrote a chapter of the Economist Intelligence Unit's Healthcare Europe in 1998. She founded and served as Chief Executive Officer of GetWellness AG from 1999 until 2002. She is currently on the board of two biotechnology companies and has helped found a cardiovascular medical device company. Catharina Maulbecker is the Chairman Europe of the Global Medical Forum Foundation.

Dr. Murray Ross
Director of Health Policy Analysis and Research
Kaiser Permanente (KP) Institute for Health Policy in Oakland, California
Dr. Ross helps plan and execute the Institute's research on a range of health care topics, including insurance coverage and market stability, technology assessment, and quality of care. In addition to his policy role, Dr. Ross advises KP leadership on Medicare and other health financing issues. He serves on the leadership team of the KP Aging Network and on the Board of Advisors to the Center for Health Services Research in Primary Care at UC-Davis. Before joining Kaiser Permanente in 2002, Dr. Ross was the first permanent executive director of the Medicare Payment Advisory Commission (MedPAC), an influential nonpartisan federal agency that advises the U.S. Congress. He was brought in to lead the integration of two predecessor commissions to MedPAC and to develop the new commission's analytic capacity to address significant changes in the Medicare program. From 1995 to 1998, Dr. Ross headed the Health Cost Estimates Unit at the Congressional Budget Office (CBO), which analyzed the impact of changes to the Medicare and Medicaid programs being considered by the Congress as it sought to balance the federal budget. He had previously worked in CBO's Health and Human Resources division, focusing on health care reform and income security policy. Dr. Ross earned his doctorate in economics from the University of Maryland, College Park, and completed his undergraduate work in economics at Arizona State University.

Dr. Patrick E. Ryce, M.D.
Senior Vice President and Medical Director
Blue Cross and Blue Shield of Alabama
Born in New Orleans, Louisiana, Dr. Ryce earned his medical degree from Louisiana State University School of Medicine. He completed his medicine internship and internal medicine residency at the University of Alabama at Birmingham Hospital, where he later served as Chief Medical Resident and Instructor in Medicine. He was certified by the American Board of Internal Medicine and practiced internal medicine in the cities of Luverne and Florence, Alabama until becoming the Medical Director at Blue Cross and Blue Shield of Alabama. He later served as Vice President and Medical Director at Blue Cross and currently serves as Senior Vice President and Medical Director, a position he has held since 1991. Dr. Ryce has served as the President of the Lauderdale County Medical Society and as a member of the Blue Cross and Blue Shield Association's National Medical Advisory Panel. He currently serves as a member of the Blue Cross and Blue Shield Association's National Council of Physician Executives.

Dr. Jane Sarasohn-Kahn
Management Consultant and Health Economist
Representative of the Institute for the Future
Jane Sarasohn-Kahn is a health economist and management consultant who has worked with health care stakeholders in the U.S., Europe and Asia for over twenty years. Focusing at the nexus of health care and technology, Jane helps clients adapt to evolving markets and public policy. Jane has assisted every segment of the health care industry throughout her career including health care providers; payers, plans and employers; technology and financial services companies; educational institutions; pharmaceutical and medical device manufacturers; consumer products companies; and, public sector and non-profit organizations. Jane founded THINK-Health in 1992 after spending ten years as a health care consultant with firms in the U.S. and Europe. In addition to managing THINK-Health, Jane has been affiliated with Institute for the Future since 1992 contributing to IFTF's annual health care forecasts. Jane is a biweekly columnist for iHealthBeat, an online publication of the California HealthCare Foundation that focuses on health care and information technology. Jane also sits on the panel of the Councils of Advisors, a group of scientific and technical professionals providing collaborative research and consulting to Wall Street analysts. Jane holds a Master of Arts in Economics and Master of Health Services Administration in Public Health Policy and Administration, as well as a Bachelor of Arts (with honors) in Economics and Journalism, all from the University of Michigan. Jane is a member of the American Public Health Association, Healthcare Financial Management Association, and the Healthcare Information and Management Systems Society. Jane is also a Fellow of the Institute of Health Services Management (United Kingdom). Jane is a frequent public speaker and writer on the subject of health policy and politics, health economics, information and medical technology and scenario planning in health care.

Dr. Sean R. Tunis, MD, MSc.
Chief Medical Officer, CMS
Director, Office of Clinical Standards & Quality
Dr. Tunis is the Director of the Office of Clinical Standards and Quality (OCSQ) and Chief Medical Officer at the Centers for Medicare and Medicaid Services (CMS). OCSQ makes evidence-based national coverage policies, sets quality standards for Medicare and Medicaid providers, leads CMS's quality measurement and improvement activities, and manages Medicare's Peer Review Program. As Chief Medical Officer, Dr. Tunis works on overall Agency clinical policy and purchasing initiatives. Dr. Tunis was previously the Director of the Coverage and Analysis Group within OCSQ. Prior to joining CMS, Dr. Tunis was a Senior Research Scientist with The Lewin Group where he led the design and conduct of prospective comparative effectiveness studies. Dr. Tunis also served as the Director of the Health Program at the Congressional Office of Technology Assessment and as a health policy advisor to the U.S. Senate Committee on Labor and Human Resources, where he participated in policy development regarding pharmaceutical and device regulation. Dr. Tunis holds an adjunct faculty position in the Department of Medicine at the Johns Hopkins School of Medicine, and practices as an Emergency Room physician in Baltimore, Maryland. He received a B.S. degree in History of Science from Cornell University, and a medical degree and masters in Health Services Research from Stanford University. Dr. Tunis did his residency training at UCLA and the University of Maryland in Emergency Medicine and Internal Medicine, and is board-certified in Internal Medicine.

 

Site Links

US Summits
GCC - ME Summits
Europe Summits
Far East Summits
GMF I Program
GMF II Program
GMF III Program
GMF IV Program
GMF V Program



U.S. Summit I:
Program
Partners
Slide Presentations
Video
Photos
Takeaways
U.S. Summit II:
Program
Partners
Slide Presentations
Video
Photos
Biographies
Takeaways

       
 
 
©2001 The Global Medical Forum. All Rights Reserved. The Global Medical Forum Logo
GMF | 2.0